Physician
John Muir Physician Network
John Muir Physician Network was paid $27.06M by Medicaid between Jan 2018 and Dec 2024, across 183 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 34% of everything it billed.
33Billing provider infoJOHN MUIR PHYSICIAN NETWORK
WALNUT CREEK, CA 94597
WALNUT CREEK, CA 94597
33aNPI1841407665assigned 05/17/2007
33bProvider typeGeneral Practice Physician
28Total paid$27.06M
24GClaims563,452
24DCodes billed183
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Practice Physician providers in California
Rank by total paid#2 of 474
Median peer was paid$10K
This provider vs. median2,610×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 25,555 | $618K | |
| 2019 | 69,239 | $2.29M | |
| 2020 | 61,122 | $2.50M | |
| 2021 | 90,609 | $4.08M | |
| 2022 | 105,134 | $4.92M | |
| 2023 | 107,699 | $5.82M | |
| 2024incomplete | 104,094 | $6.84M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 34% | 139,251 | 134,501 | $9.09M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 66,670 | 63,673 | $4.17M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 7.9% | 61,178 | 25,009 | $2.13M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 6.4% | 11,921 | 11,912 | $1.72M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 5.2% | 14,948 | 14,815 | $1.41M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 3.5% | 25,405 | 11,418 | $936K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.4% | 12,309 | 12,125 | $656K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 2.4% | 51,299 | 45,295 | $642K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.1% | 8,380 | 7,531 | $571K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 1.8% | 400 | 398 | $480K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.2% | 19,566 | 19,238 | $329K |
| 99223 | Prolong inpt eval add15 m | 1.2% | 4,437 | 4,361 | $313K |
171 more codes
| 99204 | Doctor's office visit, new patient (more involved) | 1.0% | 2,321 | $276K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 1,190 | $267K |
| 93000 | <1% | 9,029 | $218K | |
| 87428 | <1% | 3,148 | $207K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 4,076 | $197K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 2,747 | $197K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 3,827 | $178K |
| J9271 | Injection, pembrolizumab, 1 mg | <1% | 14 | $164K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 432 | $157K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 2,746 | $152K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 8,531 | $152K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 2,185 | $148K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | <1% | 409 | $132K |
| 99205 | Prolong outpt/office vis | <1% | 865 | $125K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 2,421 | $121K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 4,932 | $120K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 3,760 | $103K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 3,512 | $94K |
| 96367 | <1% | 1,521 | $91K | |
| 90686 | <1% | 7,697 | $63K | |
| 51701 | <1% | 570 | $60K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,018 | $60K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 7,233 | $54K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,413 | $51K |
| 99255 | <1% | 375 | $49K | |
| 77014 | <1% | 1,621 | $42K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,642 | $39K |
| 77427 | <1% | 332 | $39K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,156 | $38K |
| 99152 | <1% | 984 | $38K | |
| 92551 | <1% | 2,943 | $35K | |
| 0001A | <1% | 883 | $35K | |
| 0002A | <1% | 848 | $34K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 358 | $34K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 555 | $33K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 68 | $33K |
| 93296 | <1% | 1,698 | $33K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 813 | $33K |
| 93458 | <1% | 136 | $31K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,345 | $30K |
| 93297 | <1% | 2,190 | $29K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 345 | $25K |
| 93295 | <1% | 635 | $24K | |
| 81002 | <1% | 9,452 | $22K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 442 | $21K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 913 | $21K |
| 76830 | Ultrasound, transvaginal | <1% | 396 | $20K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 136 | $20K |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 1,381 | $19K |
| 0054A | <1% | 396 | $16K | |
| 99221 | <1% | 511 | $15K | |
| 73630 | <1% | 783 | $13K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 763 | $13K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 746 | $12K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 43 | $12K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 56 | $12K |
| 73564 | <1% | 647 | $11K | |
| 0071A | <1% | 281 | $11K | |
| 85018 | <1% | 3,787 | $11K | |
| J1453 | Injection, fosaprepitant, 1 mg | <1% | 88 | $11K |
| 0072A | <1% | 270 | $11K | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 485 | $10K |
| 73610 | <1% | 530 | $10K | |
| 91320 | <1% | 76 | $10K | |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | <1% | 61 | $10K |
| 76642 | <1% | 202 | $9K | |
| 99173 | <1% | 2,554 | $9K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 358 | $8K |
| 93351 | <1% | 29 | $8K | |
| 93294 | <1% | 587 | $8K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 288 | $8K |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 400 | $8K |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 43 | $8K |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 1,188 | $8K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 332 | $8K |
| 0124A | <1% | 170 | $7K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 190 | $6K |
| 0004A | <1% | 149 | $6K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 37 | $6K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 128 | $5K |
| 99000 | <1% | 3,392 | $5K | |
| 71250 | <1% | 68 | $5K | |
| 0003A | <1% | 115 | $5K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 936 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 300 | $4K |
| 90656 | <1% | 413 | $4K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 46 | $4K |
| 93016 | <1% | 139 | $4K | |
| 90480 | <1% | 103 | $4K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 38 | $4K |
| 77066 | Tomosynthesis, mammo | <1% | 44 | $4K |
| 43259 | <1% | 25 | $4K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 24 | $4K |
| 76536 | <1% | 76 | $4K | |
| 90670 | <1% | 1,341 | $3K | |
| 74018 | <1% | 203 | $3K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 601 | $3K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 120 | $3K |
| 93299 | <1% | 387 | $3K | |
| 93018 | <1% | 139 | $3K | |
| 81025 | <1% | 1,003 | $3K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 415 | $3K |
| 77334 | <1% | 37 | $3K | |
| 0052A | <1% | 68 | $3K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 12 | $3K |
| 93290 | <1% | 253 | $2K | |
| 77062 | <1% | 28 | $2K | |
| 93280 | <1% | 125 | $2K | |
| 97161 | <1% | 26 | $2K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 12 | $2K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 26 | $2K |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | <1% | 166 | $2K |
| 99243 | <1% | 12 | $2K | |
| 80053 | Comprehensive metabolic panel | <1% | 175 | $2K |
| 73140 | <1% | 116 | $1K | |
| 73130 | <1% | 81 | $1K | |
| 99153 | Mod sedat endo service >5yrs | <1% | 73 | $1K |
| 46600 | <1% | 12 | $1K | |
| 96417 | <1% | 32 | $1K | |
| 90647 | <1% | 573 | $1K | |
| 0082A | <1% | 30 | $1K | |
| 90723 | <1% | 552 | $1K | |
| 77263 | <1% | 12 | $1K | |
| 93971 | <1% | 12 | $1K | |
| 81003 | <1% | 549 | $1K | |
| 93350 | <1% | 12 | $992.90 | |
| 51741 | <1% | 24 | $977.25 | |
| 43237 | <1% | 12 | $969.03 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 313 | $921.62 |
| 0051A | <1% | 23 | $910.00 | |
| 90680 | <1% | 358 | $888.25 | |
| 73030 | <1% | 62 | $882.50 | |
| 76770 | <1% | 26 | $818.86 | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 13 | $783.64 |
| 99305 | <1% | 12 | $727.00 | |
| 77300 | <1% | 17 | $640.42 | |
| 0081A | <1% | 16 | $640.00 | |
| 99306 | Prolong nursin fac eval 15m | <1% | 30 | $635.58 |
| 20610 | <1% | 15 | $632.81 | |
| 0083A | <1% | 14 | $560.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 64 | $554.60 |
| 99442 | <1% | 37 | $541.23 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 26 | $522.44 |
| 99307 | <1% | 59 | $430.92 | |
| 90633 | <1% | 301 | $387.00 | |
| 96523 | <1% | 17 | $362.34 | |
| 99406 | <1% | 27 | $356.05 | |
| 72110 | <1% | 12 | $349.47 | |
| 91322 | <1% | 16 | $295.10 | |
| 73110 | <1% | 12 | $240.84 | |
| 99499 | <1% | 14 | $221.51 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 27 | $207.54 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 3,069 | $168.96 |
| 90685 | <1% | 43 | $131.35 | |
| 90677 | <1% | 121 | $126.00 | |
| 90696 | <1% | 44 | $103.24 | |
| 94760 | <1% | 401 | $68.93 | |
| 90688 | <1% | 32 | $66.90 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 31 | $57.29 |
| 90651 | <1% | 46 | $36.00 | |
| 90710 | <1% | 39 | $27.00 | |
| 90716 | <1% | 24 | $27.00 | |
| 90707 | <1% | 12 | $18.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 58 | $11.30 |
| 3074F | <1% | 199 | $0.01 | |
| 3078F | 0% | 308 | $0.00 | |
| 90734 | 0% | 12 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 292 | $0.00 |
| 3079F | 0% | 38 | $0.00 | |
| 99443 | 0% | 15 | $0.00 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTHOMAS, MIKE (PRESIDENT AND CEO)
| Provider | Location | Paid |
|---|---|---|
| John Muir Trauma Physicians Billing Service | Walnut Creek, CA | $328K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.